Table 2 H. pylori serostatus for different cancer sites or types and non-malignant conditions, together with the percentage of each cancer with laboratory verification of diagnosis
Cancer site or type | Percentage with laboratory verification of diagnosis | Number anti-H. pylori antibody positive/total | Odds ratio (95% CI)1 | χ21 and p value |
|---|---|---|---|---|
Stomach | 90% | 18/21 | 0.8 (0.2–2.9) | χ21 = 0.1, p = 0.7 |
All controls 2 | - | 723/833 | 1.0 | - |
Oral | 56% | 21/26 | 0.6 (0.2–1.7) | χ21 = 0.9, p = 0.4 |
Oesophagus | 45% | 37/38 | 5.1 (0.7–38) | χ21 = 2.5, p = 0.1 |
Liver | 56% | 44/52 | 0.7 (0.3–1.6) | χ21 = 0.8, p = 0.4 |
Skin | 77% | 18/22 | 0.6 (0.2–1.9) | χ21 = 0.8, p = 0.4 |
Breast | 62% | 62/69 | 1.4 (0.6–3.5) | χ21 = 0.6, p = 0.4 |
Cervix | 50% | 173/190 | 1.6 (0.9–2.8) | χ21 = 2.1, p = 0.2 |
Ovary | 73% | 20/22 | 1.1 (0.3–5.0) | χ21 = 0.0, p = 0.9 |
Prostate | 44% | 7/10 | 0.3 (0.1–1.4) | χ21 = 2.4, p = 0.1 |
Penis | 57% | 12/14 | 0.9 (0.2–4.3) | χ21 = 0.0, p = 0.9 |
Conjunctiva | 66% | 33/38 | 1.3 (0.5–3.5) | χ21 = 0.3, p = 0.6 |
Other eye | 52% | 22/25 | 1.1 (0.3–3.9) | χ21 = 0.0, p = 0.9 |
Non-Hodgkin's lymphoma | 76% | 39/46 | 0.8 (0.3–1.8) | χ21 = 0.4, p = 0.5 |
Hodgkin's lymphoma | 83% | 20/24 | 0.6 (0.2–1.9) | χ21 = 0.7, p = 0.4 |
Kaposi's sarcoma | 91% | 36/46 | 0.7 (0.3–1.6) | χ21 = 0.9, p = 0.4 |